Literature DB >> 15629835

Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.

Mark T Cahill1, Sandra S Stinnett, Avie D Banks, Sharon F Freedman, Cynthia A Toth.   

Abstract

PURPOSE: To determine patients' quality of life (QOL) after macular translocation with 360 degrees peripheral retinectomy (MT360) for age-related macular degeneration.
DESIGN: Prospective, interventional, consecutive, noncomparative case series.
METHODS: A prospective study assessed QOL 1 year after MT360 and its relation to postoperative visual function. The 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and the Medical Outcomes Study 12-item short form (SF-12) health survey were used to assess vision-related QOL and general health, respectively. Surveys were administered preoperatively and postoperatively. Postoperative NEI VFQ-25 QOL and SF-12 subscale scores for all patients were compared with the preoperative scores. Preoperative and postoperative distance and near visual acuities (VAs) and reading speed were assessed. Changes in NEI VFQ-25 QOL subscale scores were compared in patients with and without improved visual function. Postoperative NEI VFQ-25 QOL subscale scores in patients with distance VA of >or=69 Early Treatment Diabetic Retinopathy Study letters, near VA of >or=20/70, and reading speed of >or=90 words per minute were compared with subscale scores in patients with worse postoperative visual function. MAIN OUTCOME MEASURES: National Eye Institute VFQ-25 and SF-12 QOL scores and their association with distance VA, near VA, and reading speed.
RESULTS: In total, 50 patients with a mean age of 76.9 years were studied. Postoperative mean NEI VFQ-25 QOL scores were higher than the preoperative mean scores, and this difference was significant for important vision-specific subscales. Patients with improved visual function had greater mean changes in NEI VFQ-25 QOL scores than those with no improvement. Patients with the outlined higher levels of visual function had greater mean NEI VFQ-25 QOL scores than those who had worse visual function. Preoperative and postoperative mean SF-12 QOL scores were similar.
CONCLUSIONS: Macular translocation with 360 degrees peripheral retinectomy was associated with improvement in vision-related QOL. The amount of improvement was greatest in patients with postoperative improvement in visual function, and the best postoperative vision-related QOL was seen in patients with better postoperative visual function. This was not associated with a change in patients' general health.

Entities:  

Mesh:

Year:  2005        PMID: 15629835     DOI: 10.1016/j.ophtha.2004.06.035

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Visual quality of life after macular hole surgery: outcome and predictive factors.

Authors:  Christoph Hirneiss; Aljoscha S Neubauer; Carolin A Gass; Ingrid W Reiniger; Siegfried G Priglinger; Anselm Kampik; Christos Haritoglou
Journal:  Br J Ophthalmol       Date:  2006-10-31       Impact factor: 4.638

2.  Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration--a report of 1 year results.

Authors:  Matthias Lüke; Focke Ziemssen; Karl Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-09       Impact factor: 3.117

3.  Time-dependent effects on contrast sensitivity, near and distance acuity: difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation).

Authors:  Focke Ziemssen; Matthias Lüke; Karl U Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-12-11       Impact factor: 3.117

Review 4.  Retinal pigment epithelium transplantation: concepts, challenges, and future prospects.

Authors:  P Alexander; H A J Thomson; A J Luff; A J Lotery
Journal:  Eye (Lond)       Date:  2015-06-05       Impact factor: 3.775

5.  Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

Authors:  Matthias Lüke; Focke Ziemssen; Michael Völker; Elke Altpeter; Julia Beutel; Dorothea Besch; Karl Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-12       Impact factor: 3.117

6.  Recurrent choroidal neovascularization after macular translocation surgery with 360-degree peripheral retinectomy.

Authors:  Claxton A Baer; Catherine Bowes Rickman; Sunil Srivastava; Goldis Malek; Sandra Stinnett; Cynthia A Toth
Journal:  Retina       Date:  2008-10       Impact factor: 4.256

7.  Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools.

Authors:  Robert P Finger; Monika Fleckenstein; Frank G Holz; Hendrik P N Scholl
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

8.  Visual function and vision-related quality of life after vitrectomy for idiopathic macular hole: a 12mo follow-up study.

Authors:  Hong-Tao Duan; Song Chen; Yue-Xin Wang; Jia-Hui Kong; Meng Dong
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

9.  Assessment of vision-related quality of life in patients with homonymous visual field defects.

Authors:  Eleni Papageorgiou; Gregor Hardiess; Frank Schaeffel; Horst Wiethoelter; Hans-Otto Karnath; Hanspeter Mallot; Birgitt Schoenfisch; Ulrich Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-25       Impact factor: 3.117

10.  The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Authors:  Keith Evans; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Clin Ophthalmol       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.